Sarsys Balance Sheet Health
Financial Health criteria checks 3/6
Sarsys has a total shareholder equity of SEK5.4M and total debt of SEK11.7M, which brings its debt-to-equity ratio to 219.2%. Its total assets and total liabilities are SEK43.6M and SEK38.3M respectively.
Key information
219.2%
Debt to equity ratio
kr11.75m
Debt
| Interest coverage ratio | n/a |
| Cash | kr1.05m |
| Equity | kr5.36m |
| Total liabilities | kr38.26m |
| Total assets | kr43.62m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: SARS's short term assets (SEK20.2M) do not cover its short term liabilities (SEK29.7M).
Long Term Liabilities: SARS's short term assets (SEK20.2M) exceed its long term liabilities (SEK8.6M).
Debt to Equity History and Analysis
Debt Level: SARS's net debt to equity ratio (199.6%) is considered high.
Reducing Debt: SARS's debt to equity ratio has increased from 118.3% to 219.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable SARS has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: SARS is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 72.6% per year.